glp-1 boom 1 in 9 Americans is on a right now. Almost none of them are told the full story. Swipe through for what actually happens in your body on these medications, why GLP-1 Boom Sparks Potential 'Bubble

JCI Insight (2023) 8(11):e166001

In November, Lilly and Novo agreed with the Trump administration to cut US prices for Medicare and cash-paying customers, including a $149 monthly price for the lowest doses of their forthcoming pills, while Medicare coverage is set to expand around the middle of next year with patient out-of-pocket costs of about $50 a month

10.1016/j.fertnstert.2011.08.034 40

These screening tests cannot predict with complete accuracy who will or will not develop preeclampsia, they are another means by which doctors can help assess the likelihood a patient may be at risk for developing this condition